Godavari Drugs standalone net profit declines 1.55% in the March 2022 quarter

Sales rise 34.34% to Rs 44.28 crore

Net profit of Godavari Drugs declined 1.55% to Rs 1.27 crore in the quarter ended March 2022 as against Rs 1.29 crore during the previous quarter ended March 2021. Sales rose 34.34% to Rs 44.28 crore in the quarter ended March 2022 as against Rs 32.96 crore during the previous quarter ended March 2021.

For the full year,net profit rose 27.12% to Rs 5.25 crore in the year ended March 2022 as against Rs 4.13 crore during the previous year ended March 2021. Sales rose 31.34% to Rs 161.11 crore in the year ended March 2022 as against Rs 122.67 crore during the previous year ended March 2021.

 

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales44.2832.96 34 161.11122.67 31 OPM %6.127.80 -7.018.01 - PBDT2.211.87 18 8.736.93 26 PBT1.791.50 19 7.035.71 23 NP1.271.29 -2 5.254.13 27

Powered by Capital Market - Live News